Detalhe da pesquisa
1.
Design, synthesis and antiproliferative activity evaluation of m-(4-morpholinyl-1,3,5-triazin-2-yl)benzamides in vitro.
Bioorg Med Chem Lett
; 25(8): 1730-1735, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25765909
2.
Synthesis and antitumor activity evaluation of PI3K inhibitors containing 3-substituted quinazolin-4(3H)-one moiety.
Bioorg Med Chem
; 23(24): 7765-76, 2015 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26652969
3.
Modification of N-(6-(2-methoxy-3-(4-fluorophenylsulfonamido)pyridin-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)acetamide as PI3Ks inhibitor by replacement of the acetamide group with alkylurea.
Bioorg Med Chem
; 23(17): 5662-71, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26210161
4.
Synthesis and anticancer effects evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylaminopyridin-5-yl)benzo[d]thiazol-2-yl)urea as anticancer agents with low toxicity.
Bioorg Med Chem
; 23(19): 6477-85, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26321603
5.
Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo.
Eur J Med Chem
; 96: 382-95, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25911625